Literature DB >> 19958364

Aberrant DNA methylation in contrast with mutations.

Toshikazu Ushijima1, Kiyoshi Asada.   

Abstract

Aberrant DNA methylation is known as an important cause of human cancers, along with mutations. Although aberrant methylation was initially speculated to be similar to mutations, it is now recognized that methylation is quite unlike mutations. Whereas the number of mutations in individual cancer cells is estimated to be approximately 80, that of aberrant methylation of promoter CpG islands reaches several hundred to 1000. Although mutations of a specific gene are very few in non-cancerous (thus polyclonal) tissues (usually at 1 x 10(-5)/cell), aberrant methylation of a specific gene can be present up to several 10% of cells. Mutagenic chemicals and radiation are well-known inducers of mutations, whereas chronic inflammation is deeply involved in methylation induction. Although mutations are induced in mostly random genes, methylation is induced in specific genes depending on tissues and inducers. Methylation is potentially reversible, unlike mutations. These characteristics of methylation are opening up new fields of application and research.

Entities:  

Mesh:

Year:  2009        PMID: 19958364     DOI: 10.1111/j.1349-7006.2009.01434.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  38 in total

1.  Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.

Authors:  Peter B Makhov; Konstantin V Golovine; Alexander Kutikov; Daniel J Canter; Vera A Rybko; Dmitry A Roshchin; Vsevolod B Matveev; Robert G Uzzo; Vladimir M Kolenko
Journal:  Carcinogenesis       Date:  2011-09-22       Impact factor: 4.944

Review 2.  Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.

Authors:  Alexander Link; Francesc Balaguer; Ajay Goel
Journal:  Biochem Pharmacol       Date:  2010-06-26       Impact factor: 5.858

Review 3.  An overview of epigenetics and chemoprevention.

Authors:  Yi-Wen Huang; Chieh-Ti Kuo; Kristen Stoner; Tim H-Y Huang; Li-Shu Wang
Journal:  FEBS Lett       Date:  2010-11-05       Impact factor: 4.124

Review 4.  Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.

Authors:  Mary Beth Terry; Jasmine A McDonald; Hui Chen Wu; Sybil Eng; Regina M Santella
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

5.  Novel risk markers for gastric cancer screening: Present status and future prospects.

Authors:  Shotaro Enomoto; Takao Maekita; Hiroshi Ohata; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  World J Gastrointest Endosc       Date:  2010-12-16

Review 6.  Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.

Authors:  Yoshifumi Baba; Asuka Murata; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2013-10-23       Impact factor: 2.549

Review 7.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

8.  Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk among tissues.

Authors:  Satoshi Yamashita; Takayoshi Kishino; Takamasa Takahashi; Taichi Shimazu; Hadrien Charvat; Yasuo Kakugawa; Takeshi Nakajima; Yi-Chia Lee; Naoko Iida; Masahiro Maeda; Naoko Hattori; Hideyuki Takeshima; Reiko Nagano; Ichiro Oda; Shoichiro Tsugane; Ming-Shiang Wu; Toshikazu Ushijima
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-22       Impact factor: 11.205

9.  Body mass and DNA promoter methylation in breast tumors in the Western New York Exposures and Breast Cancer Study.

Authors:  Meng-Hua Tao; Catalin Marian; Jing Nie; Christine Ambrosone; Shiva S Krishnan; Stephen B Edge; Maurizio Trevisan; Peter G Shields; Jo L Freudenheim
Journal:  Am J Clin Nutr       Date:  2011-07-20       Impact factor: 7.045

10.  Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells.

Authors:  Linlin Shao; Zheng Chen; Wael El-Rifai; Dunfa Peng; Mohammed Soutto; Shoumin Zhu; Andreia Bates; Shutian Zhang
Journal:  Mol Cancer Res       Date:  2018-02-16       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.